Verrica Pharmaceuticals (VRCA) Assets (2017 - 2026)
Verrica Pharmaceuticals (VRCA) recorded Assets of $36.02 million in Q2 2026, down 7.9% from $39.11 million a year earlier and down 7.1% from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Verrica Pharmaceuticals reported Assets of $47.13 million, down 12.9% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $54.13 million in FY2024 (-33.7%), $81.6 million in FY2023 (+82.5%), $44.72 million in FY2022 (-44.2%) and $80.13 million in FY2021 (+8.1%).
- The Q2 2026 figure is the lowest quarterly Assets since Q3 2024.
- On a year-over-year basis, Assets has declined for three consecutive quarters, with an average decline of 20.7% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 97.7% in Q3 2023, against a decline of 66.1% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $38.79 million (Q1 2026), $47.13 million (Q4 2025) and $40.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Verrica Pharmaceuticals | 62.02 Mn | -21.03 Mn | - | 36.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.02 Mn |
| Mar 31, 2026 | 38.79 Mn |
| Dec 31, 2025 | 47.13 Mn |
| Sep 30, 2025 | 40.90 Mn |
| Jun 30, 2025 | 39.11 Mn |
| Mar 31, 2025 | 42.18 Mn |
| Dec 31, 2024 | 54.13 Mn |
| Sep 30, 2024 | 32.93 Mn |
| Jun 30, 2024 | 52.01 Mn |
| Mar 31, 2024 | 66.31 Mn |
| Dec 31, 2023 | 81.60 Mn |
| Sep 30, 2023 | 97.15 Mn |
| Jun 30, 2023 | 62.20 Mn |
| Mar 31, 2023 | 68.64 Mn |
| Dec 31, 2022 | 44.72 Mn |
| Sep 30, 2022 | 49.15 Mn |
| Jun 30, 2022 | 63.44 Mn |
| Mar 31, 2022 | 71.62 Mn |
| Dec 31, 2021 | 80.13 Mn |
| Sep 30, 2021 | 88.76 Mn |
API Access
Verrica Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();